IVD Medical of Hong Kong Adds $19 Million Worth of ETH to Corporate Reserves

IVD Medical Acquires $19M in Ether to Power Tokenization Strategy and Crypto Treasury

Hong Kong-listed IVD Medical Holdings has purchased $19 million (HK$149 million) worth of ether (ETH), integrating the asset as both a core treasury holding and the backbone of its forthcoming tokenization platform, ivd.xyz.

The ivd.xyz platform will tokenize pharmaceutical IP and healthcare assets, operating entirely on Ethereum. The company said ETH will support on-chain settlements, governance, and revenue distribution, while also backing a planned IVDD stablecoin aimed at enabling cross-border transactions within regulatory frameworks in Hong Kong and the U.S.

Chief Strategy Officer Gary Deng cited Ethereum’s liquidity, institutional momentum, and regulatory clarity—highlighted by the recent U.S. SEC approval of spot ETH ETFs—as key reasons for choosing ETH as its core asset.

The firm also intends to deploy ETH into staking, re-staking, and on-chain derivatives, aiming to enhance yield and protect downside risk. Revenue generated from tokenized asset transactions will be converted into ETH and added to the treasury.

IVD joins a small group of Hong Kong-listed firms actively holding crypto assets. While most—including Boyaa Interactive and Meitu—favor bitcoin, IVD’s ETH-focused approach sets it apart. Boyaa holds over 3,100 BTC valued at more than $300 million, while Meitu previously held a significant ETH position before exiting the market.

The announcement follows the company’s strategic partnership with HashKey Group, operator of the licensed HashKey Exchange.